• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.

作者信息

Conforti Claudio, Giuffrida Roberta, Dianzani Caterina, Di Meo Nicola, Zalaudek Iris

机构信息

Department of Dermatology and Venereology, Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.

Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, Messina, Italy.

出版信息

Dermatol Ther. 2020 Jul;33(4):e13490. doi: 10.1111/dth.13490. Epub 2020 May 20.

DOI:10.1111/dth.13490
PMID:32358864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7261974/
Abstract
摘要

相似文献

1
Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.2019冠状病毒病疫情期间银屑病的生物治疗：选择需权衡风险与获益。
Dermatol Ther. 2020 Jul;33(4):e13490. doi: 10.1111/dth.13490. Epub 2020 May 20.
2
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.在新冠疫情期间，银屑病的生物治疗并非一种选择。
J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6.
3
COVID-19 in an elderly patient treated with secukinumab.一位接受司库奇尤单抗治疗的老年患者的新型冠状病毒肺炎
Dermatol Ther. 2020 Jul;33(4):e13580. doi: 10.1111/dth.13580. Epub 2020 May 27.
4
Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.银屑病、新冠病毒肺炎与急性呼吸窘迫综合征：关注联合生物治疗的风险
Dermatol Ther. 2020 Jul;33(4):e13706. doi: 10.1111/dth.13706. Epub 2020 Jun 19.
5
Reply: "Biologics for psoriasis during COVID-19 outbreak".回复：“新冠疫情期间用于银屑病的生物制剂”
J Am Acad Dermatol. 2020 Jun;82(6):e217-e218. doi: 10.1016/j.jaad.2020.04.004. Epub 2020 Apr 10.
6
Antipsoriatic treatments during COVID-19 outbreak.新冠疫情期间的银屑病治疗
Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10.
7
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".关于《COVID-19与银屑病：是时候限制免疫抑制剂治疗了吗？行动呼吁》的评论
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
8
Comment on "Antipsoriatic treatments during COVID-19 outbreak".关于“新冠肺炎疫情期间的银屑病治疗”的评论
Dermatol Ther. 2020 Jul;33(4):e13491. doi: 10.1111/dth.13491. Epub 2020 Jun 12.
9
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
10
Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution".回复：“2019冠状病毒病、梅毒与银屑病和银屑病关节炎的生物疗法：一则警示”
J Am Acad Dermatol. 2020 Jun;82(6):e215. doi: 10.1016/j.jaad.2020.03.103. Epub 2020 Apr 10.

引用本文的文献

1
Biologics and Biosimilars in Psoriasis.银屑病中的生物制剂和生物类似药
Indian J Dermatol. 2023 May-Jun;68(3):282-295. doi: 10.4103/ijd.ijd_421_23.
2
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis.新冠病毒疫苗在接受生物制剂治疗的银屑病患者中的安全性和有效性。
Psoriasis (Auckl). 2023 Apr 12;13:11-18. doi: 10.2147/PTT.S398135. eCollection 2023.
3
COVID-19 Knowledge in Patients with Psoriasis Receiving Systemic Therapy: a Questionnaire Study.接受全身治疗的银屑病患者的新冠病毒知识：一项问卷调查研究。
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022166. doi: 10.5826/dpc.1204a166. eCollection 2022 Nov.
4
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.2019年冠状病毒病大流行对皮肤病的影响：一项新颖的全面综述
Dermatopathology (Basel). 2022 Jun 29;9(3):212-243. doi: 10.3390/dermatopathology9030027.
5
Biologics for Psoriasis during the COVID-19 Pandemic.新冠疫情期间用于治疗银屑病的生物制剂
J Clin Med. 2021 Mar 30;10(7):1390. doi: 10.3390/jcm10071390.
6
The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul.COVID-19 对银屑病患者的影响：伊斯坦布尔的一项多中心研究。
Dermatol Ther. 2021 Jan;34(1):e14691. doi: 10.1111/dth.14691. Epub 2020 Dec 30.
7
Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.COVID-19 大流行中的皮肤表现和注意事项：系统评价。
Dermatol Ther. 2020 Nov;33(6):e13986. doi: 10.1111/dth.13986. Epub 2020 Aug 6.
8
Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies? A systematic review.患有特定皮肤疾病且受 COVID-19 影响的患者：管理策略的经验有何说法？系统评价。
Dermatol Ther. 2020 Nov;33(6):e13867. doi: 10.1111/dth.13867. Epub 2020 Jul 7.
9
Contributions of dermatologists to COVID-19 research: A brief systematic review.皮肤科医生对 COVID-19 研究的贡献：简要系统评价。
Dermatol Ther. 2020 Jul;33(4):e13713. doi: 10.1111/dth.13713. Epub 2020 Jul 2.

本文引用的文献

1
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.在新冠疫情期间，银屑病的生物治疗并非一种选择。
J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6.
2
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".关于《COVID-19与银屑病：是时候限制免疫抑制剂治疗了吗？行动呼吁》的评论
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
3
Antipsoriatic treatments during COVID-19 outbreak.新冠疫情期间的银屑病治疗
Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10.
4
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.